Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Coloplast A/S    COLO B   DK0060448595

COLOPLAST A/S (COLO B)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 10/20 04:59:58 pm
549.5 DKK   +0.92%
09/12 COLOPLAST A/S : Insider tradings
08/24 COLOPLAST A/S : Announcement no. 6/2017 - Financial calendar 2017/18
08/18 COLOPLAST A/S : delivers satisfactory Q3 result
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Copenhagen
10/16/2017 10/17/2017 10/18/2017 10/19/2017 10/20/2017 Date
548.5(c) 543.5(c) 552(c) 544.5(c) 549.5(c) Last
262 421 284 191 263 185 254 796 270 216 Volume
+0.27% -0.91% +1.56% -1.36% +0.92% Change
More quotes
Financials ( DKK)
Sales 2017 15 593 M
EBIT 2017 5 054 M
Net income 2017 3 813 M
Debt 2017 1 183 M
Yield 2017 2,55%
Sales 2018 16 683 M
EBIT 2018 5 522 M
Net income 2018 4 214 M
Debt 2018 872 M
Yield 2018 2,80%
P/E ratio 2017 30,02
P/E ratio 2018 27,09
EV / Sales2017 6,99x
EV / Sales2018 6,51x
Capitalization 108 B
More Financials
Company
Coloplast A/S develops, manufactures, and markets medical products.It operates through the following segments: Chronic Care, Urology Care and Wound & Skin Care.The Chronic Care segment covers the sale of ostomy care products and continence care products.The Urology Care segment covers the sale of... 
More about the company
Surperformance© ratings of Coloplast A/S
Trading Rating : Investor Rating :
More Ratings
Latest news on COLOPLAST A/S
09/21 COLOPLAST A/S : Patent Issued for Method of Placing Suture through Tissue with a..
09/14 COLOPLAST A/S : Patent Issued for Method of Providing a Patient with an Implante..
09/14 COLOPLAST A/S : Patent Issued for Surgical System for and a Method of Identifyin..
09/12 COLOPLAST A/S : Insider tradings
09/07 COLOPLAST A/S : Patent Issued for Method of Treating Prolapse of a Vagina by Pro..
09/07 COLOPLAST A/S : Patent Issued for Incontinence Treatment Device (USPTO 9744016)
08/24 COLOPLAST A/S : Announcement no. 6/2017 - Financial calendar 2017/18
08/18 COLOPLAST A/S : delivers satisfactory Q3 result
08/18 COLOPLAST A/S : Announcement no. 5/2017 - Meet the Management Event
08/17 COLOPLAST A/S : Patent Issued for Tool with a Suction Feature Useful for Implant..
More news
Sector news : Medical Equipment Wholesale
10/16DJDentsply General Counsel Exits, Marking Fourth Resignation in Recent Weeks --..
10/16DJDentsply Sirona General Counsel Exits, Marking Fourth Resignation in Recent W..
10/13 Toshiba discussing joint investment in chips with Western Digital
10/11 Mondi drags on FTSE, Provident Financial sinks
10/10 SMITH & NEPHEW : Elliott Management builds stake in Smith & Nephew - Bloomberg
More sector news : Medical Equipment Wholesale
Latest Tweets
10/04EU Movers: William Hill +2.0% Tesco +1.5% Coloplast +1.3% Tullow Oil -2.7% ..
3
09/24Coloplast A/S $CLPBY Stock Rating Upgraded by Zacks Investment Research  
09/23Coloplast A/S upgraded by Zacks Investment Research to buy. $9.00 PT.  
09/22Coloplast A/S downgraded by Zacks Investment Research to hold.  
09/18Global Intermittent Catheters Market 2017-2021 with Coloplast, C.R Bard, Holl.. 
More tweets
Qtime:22
News from SeekingAlpha
08/21 Coloplast (CLPBY) Investor Presentations - Slideshow
08/17 Coloplast's (CLPBF) CEO Lars Rasmussen on Q3 2017 Results - Earnings Call Tra..
08/16 Coloplast AS ADR 2017 Q3 - Results - Earnings Call Slides
08/16 Coloplast ASB reports Q3 results
05/03 Coloplast's (CLPBF) CEO Lars Rasmussen on Q2 2017 Results - Earnings Call Tra..
Chart COLOPLAST A/S
Duration : Period :
Coloplast A/S Technical Analysis Chart | COLO B | DK0060448595 | 4-Traders
Technical analysis trends COLOPLAST A/S
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 23
Average target price 550  DKK
Spread / Average Target 0,92%
EPS Revisions
Managers
NameTitle
Lars Søren Rasmussen President & Chief Executive Officer
Michael Pram Rasmussen Chairman
Allan Rasmussen Executive Vice President-Global Operations
Anders Lonning-Skovgaard CFO, Executive VP & Head-Investor Relations
Oliver Johansen Senior VP-Global Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
COLOPLAST A/S15.89%17 322
HENRY SCHEIN9.54%13 011
CANTEL MEDICAL CORP.22.78%4 035
PATTERSON COMPANIES, INC.-5.44%3 649
AMPLIFON SPA42.10%3 430
MERIT MEDICAL SYSTEMS, INC.59.06%2 113